Healthcare -
Biotechnology - NASDAQ - US
$ 5.68
1.52 %
$ 253 M
Market Cap
-1.81
P/E
Price Target
Average
58.45%
Revenue Forecast
Estimate
-0.00%
EBIT
Estimate
--28.33%
Net Income
Estimate
31.60%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Verastem, Inc.
Wall Street analysts predict an average 1-year price target for VSTM of $9 , with forecasts ranging from
a
low of
$5 to a high of $13 .
VSTM Lowest Price Target
Wall Street Target
5 USD
-11.97%
VSTM Average Price Target
Wall Street Target
9 USD
58.45%
VSTM Highest Price Target
Wall Street Target
13 USD
128.87%
REVENUE FORECAST
Revenue Forecast Chart VSTM
EBIT FORECAST
EBIT Forecast Chart VSTM
NET INCOME FORECAST
Net Income Chart VSTM